Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Date
On January 14, 2021, the Food and Drug Administration approved crizotinib (Xalkori, Pfizer Inc.) for pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. The safety and efficacy of crizotinib have not been established in older adults with relapsed or refractory, systemic ALK-positive ALCL. Read more.
The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO) understand the challenges facing the cancer community during the COVID-19 pandemic—from determining the best treatment for patients, to addressing whether people with cancer should receive the COVID-19 vaccine. ASCO is advocating for individuals with cancer to receive priority status for the vaccine given their increased risk for severe infection.
The American Medical Association (AMA) has developed a tool to help select the appropriate CPT® code for the type and dose of vaccine that is being administered.
With practices facing difficulty in gaining access to gloves, Project N95 is once again collaborating with ASCO to offer qualifying members access to smooth 12” long latex free, powder free 6-7mil chemo grade gloves at accessible prices in small or large quantities. The deadline to purchase is Thursday, January 14 to guarantee that your purchase ships by January 31. Learn more and purchase at: shop.projectn95.org.
ASCO recently released new recommendations designed to improve the effectiveness and efficiency of the clinical trial site feasibility assessment process to ensure that more trial sites and patients can participate in clinical trials. These recommendations also help address a goal established in ASCO’s Road to Recovery report to simplify, streamline, and standardize clinical trials. Learn more.
ASCO recently developed a new resource page that gathers a wide range of materials to help members work toward achieving health equity in cancer research and care. The page has position statements, pivotal research, online educational series, and ways to get involved. Continue to check back for new resources as the initiative continues! Learn more.
Retiring ASCO Chief Medical Officer Dr. Richard L Schilsky gives a far-reaching interview with ASCO in Action podcast host ASCO CEO Dr. Clifford A. Hudis, who examines Dr. Schilsky’s trailblazing medical career, his leadership in ASCO and indelible mark on its research enterprise, and what he sees for the future of oncology. Listen now.